CN1142272C - 携带人肝细胞生长因子基因的重组腺病毒的用途 - Google Patents
携带人肝细胞生长因子基因的重组腺病毒的用途 Download PDFInfo
- Publication number
- CN1142272C CN1142272C CNB001007394A CN00100739A CN1142272C CN 1142272 C CN1142272 C CN 1142272C CN B001007394 A CNB001007394 A CN B001007394A CN 00100739 A CN00100739 A CN 00100739A CN 1142272 C CN1142272 C CN 1142272C
- Authority
- CN
- China
- Prior art keywords
- recombinant adenovirus
- adenovirus
- growth factor
- carrier
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (5)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001007394A CN1142272C (zh) | 2000-02-02 | 2000-02-02 | 携带人肝细胞生长因子基因的重组腺病毒的用途 |
US09/775,534 US20010039048A1 (en) | 2000-02-02 | 2001-02-01 | Recombinant adenovirus and its use for the prevention and treatment of fibrotic disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001007394A CN1142272C (zh) | 2000-02-02 | 2000-02-02 | 携带人肝细胞生长因子基因的重组腺病毒的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1307102A CN1307102A (zh) | 2001-08-08 |
CN1142272C true CN1142272C (zh) | 2004-03-17 |
Family
ID=4575644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001007394A Expired - Lifetime CN1142272C (zh) | 2000-02-02 | 2000-02-02 | 携带人肝细胞生长因子基因的重组腺病毒的用途 |
Country Status (2)
Country | Link |
---|---|
US (1) | US20010039048A1 (zh) |
CN (1) | CN1142272C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020119424A1 (zh) | 2018-12-14 | 2020-06-18 | 中国药科大学 | 一种含有sumo抑制剂的组合物及应用 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003030720A2 (en) * | 2001-10-09 | 2003-04-17 | The Children's Hospital Of Philadelphia | Materials and methods for preventing or reducing scar formation |
KR100562824B1 (ko) * | 2002-03-20 | 2006-03-23 | 주식회사 바이로메드 | 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자 |
CN100441226C (zh) * | 2002-04-26 | 2008-12-10 | 中国人民解放军军事医学科学院放射医学研究所 | 用于加速创伤修复及防治并发症的方法 |
DE60332748D1 (de) * | 2002-10-02 | 2010-07-08 | Anges Mg Inc | Arzneimittel gegen hörfunktionsstörungen |
WO2008011216A2 (en) | 2006-05-16 | 2008-01-24 | Pro-Pharmaceuticals, Inc. | Galactose-pronged polysaccharides in a formulation for antifibrotic therapies |
CN101864452B (zh) * | 2009-04-16 | 2012-01-11 | 中国人民解放军军事医学科学院军事兽医研究所 | 一种双特异抗肿瘤重组腺病毒及其构建方法和应用 |
BR112014006220A2 (pt) * | 2011-09-16 | 2017-04-11 | Galectin Therapeutics Inc | composições de galacto-ramnogalacturonato para o tratamento de esteatohepatite não alcoólica e de doença de gordura no fígado não alcoólica |
BR112014030534A2 (pt) | 2012-06-06 | 2017-06-27 | Galectin Therapeutics Inc | composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada |
CN103446188B (zh) * | 2013-09-02 | 2017-01-25 | 中国人民解放军第三军医大学第一附属医院 | Tradd基因过表达慢病毒在抑制皮肤疤痕形成中的应用 |
CN114392361B (zh) * | 2022-01-23 | 2023-06-02 | 重庆医科大学附属儿童医院 | 一种羧甲基壳聚糖-腺病毒混合物及其应用 |
CN115161289B (zh) * | 2022-03-14 | 2023-12-05 | 东南大学 | 一种用于炎症性疾病治疗的重组腺相关病毒及其构建方法和应用 |
-
2000
- 2000-02-02 CN CNB001007394A patent/CN1142272C/zh not_active Expired - Lifetime
-
2001
- 2001-02-01 US US09/775,534 patent/US20010039048A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020119424A1 (zh) | 2018-12-14 | 2020-06-18 | 中国药科大学 | 一种含有sumo抑制剂的组合物及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1307102A (zh) | 2001-08-08 |
US20010039048A1 (en) | 2001-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1142272C (zh) | 携带人肝细胞生长因子基因的重组腺病毒的用途 | |
AU2013216920B2 (en) | Compartmentalized method of nucleic acid delivery and compositions and uses thereof | |
DE69429260T3 (de) | Adenovirale vektoren tierischen ursprungs und ihre verwendung bei der gentherapie | |
DE69827021T2 (de) | An verschiedenen orten verabreichung von adenoviren-vektor zur induzierung von angiogenese | |
RU2146148C1 (ru) | Терапевтическое применение фактора роста кератиноцитов (фрк) | |
EP2234628A2 (en) | Compositions and methods of promoting wound healing | |
JP2003502350A (ja) | 傷癒合促進用促進傷被覆材 | |
Ha et al. | Effect of human hepatocyte growth factor on promoting wound healing and preventing scar formation by adenovirus-mediated gene transfer | |
US20160331809A1 (en) | The use of sdf-1 to mitigate scar formation | |
JP2024026118A (ja) | 突発性の過活動膀胱症候群及び排尿筋過活動を処置するための組成物及び方法 | |
CN115725500A (zh) | 脂肪间充质干细胞外泌体、其制备方法及其应用 | |
EP2890777B1 (en) | A pharmaceutical composition comprising pcmv-vegf165 for stimulation of angiogenesis | |
US6342214B1 (en) | Method for viral vector delivery | |
CZ20023426A3 (cs) | Přípravek mající mobilizační aktivitu | |
CN101182493A (zh) | 一种治疗放射性肠炎的转基因间充质干细胞及其制备方法 | |
Murakami et al. | Atrial natriuretic peptide gene delivery attenuates gentamycin-induced nephrotoxicity in rats. | |
CN108606981B (zh) | 运用MSCs定向趋化特性运载EPO治疗肺纤维化 | |
CN112023031A (zh) | SNase在制备促进糖尿病伤口愈合药物中的应用 | |
CN107041948A (zh) | 细胞生长因子治疗溃疡性疾病和肺纤维化疾病的应用 | |
CN116790612B (zh) | 一种促进心肌再生修复的过氧化物酶体生发蛋白3及其应用 | |
CN1250287C (zh) | 一种重组腺病毒在脑缺血、创伤修复和组织粘连治疗中的应用 | |
DE69936320T2 (de) | Zellbasierte gentherapie für das lungensystem | |
WO2023019913A1 (zh) | 一种诱导剂、巨噬细胞及其应用 | |
DE19940012A1 (de) | Neues Mittel aus mindestens zwei Komponenten, das zum einen Gefäßneubildung (Neoangiogense) induziert des weiteren jedoch auch Gefäßverschlüsse (Restenosen) verhindert, das Verfahren seiner Herstellung und seine Verwendung | |
CN114504658B (zh) | 一种治疗阿霉素诱导的心脏毒性损伤的药物及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: EMISSION AND RADIATION MEDICAL RESEARCH INSTITUTE Free format text: FORMER NAME: BAIHUAN BIOMEDICAL RESEARCH CENTER, ACADEMY OF MILITARY MEDICAL SCIENCES, PLA |
|
CP01 | Change in the name or title of a patent holder |
Address after: 100850 No. 27, Taiping Road, Beijing, two Patentee after: Emission and Radiation Medical Research Institute Address before: 100850 No. 27, Taiping Road, Beijing, two Patentee before: Baihuan Biomedical Research Center, Academy of Military Medical Sciences, PLA |
|
CX01 | Expiry of patent term |
Granted publication date: 20040317 |
|
CX01 | Expiry of patent term |